TrialGynecologic oncology2012

A phase II evaluation of belinostat and carboplatin in the treatment of recurrent or persistent platinum-resistant ovarian, fallopian tube, or primary peritoneal carcinoma: a Gynecologic Oncology Group study.

Don S Dizon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.